Vahlne; Anders

Patent Applications and Registrations

Patent applications and USPTO patent grants for Vahlne; Anders.The latest application filed is for "high affinity adaptor molecules for redirecting antibody specifity".

Company Profile

0.13.19

Vahlne; Anders - Stockholm SE
Vahlne; Anders - Bastad SE
Vahlne; Anders - Bastard SE
Vahlne, Anders - Hovas SE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
High Affinity Adaptor Molecules For Redirecting Antibody Specifity App 20160251400 - Collinson; Albert ; et al.	2016-09-01
High affinity adaptor molecules for redirecting antibody specifity Grant 9,284,548 - Collinson , et al. March 15, 2	2016-03-15
Glycosylated specificity exchangers Grant 9,079,962 - Sallberg , et al. July 14, 2	2015-07-14
Glycosylated Specificity Exchangers App 20140081004 - Sallberg; Matti ; et al.	2014-03-20
Glycosylated specificity exchangers Grant 8,658,179 - Sallberg , et al. February 25, 2	2014-02-25
Glycosylated Specificity Exchangers App 20130041131 - Sallberg; Matti ; et al.	2013-02-14
Glycosylated specificity exchangers Grant 8,303,956 - Sallberg , et al. November 6, 2	2012-11-06
High Affinity Adaptor Molecules For Redirecting Antibody Specifity App 20120271033 - Collinson; Albert ; et al.	2012-10-25
Glycosylated Specificity Exchangers App 20100183635 - Sallberg; Matti ; et al.	2010-07-22
Indentification Of Compounds That Inhibit Replication Of Human Immunodeficiency Virus App 20090170953 - Balzarini; Jan Maria ; et al.	2009-07-02
Glycosylated specificity exchangers Grant 7,534,435 - Sallberg , et al. May 19, 2	2009-05-19
Glycosylated Specificity Exchangers That Induce An Antibody Dependent Cellular Cytotoxicity (adcc) Response App 20090092631 - Sallberg; Matti ; et al.	2009-04-09
Compounds That Inhibit Replication Of Human Immunodeficiency Virus App 20080076824 - Balzarini; Jan Maria Rene ; et al.	2008-03-27
Glycosylated specificity exchangers Grant 7,335,359 - Sallberg , et al. February 26, 2	2008-02-26
Glycosylated specificity exchangers Grant 7,332,166 - Sallberg , et al. February 19, 2	2008-02-19
Molecules that block viral infectivity and methods of use thereof App 20070037249 - Goobar-Larsson; Laura ; et al.	2007-02-15
Identification of compounds that inhibit replication of human immunodeficiency virus App 20060188920 - Balzarini; Jan Maria Rene ; et al.	2006-08-24
Identification of compounds that inhibit replication of human immunodeficiency virus App 20060183748 - Balzarini; Jan Maria Rene ; et al.	2006-08-17
Antiviral composition comprising glycine amide Grant 7,012,129 - Vahlne , et al. March 14, 2	2006-03-14
Identification of compounds that inhibit replication of human immunodeficiency virus App 20050096319 - Balzarini, Jan Maria Rene ; et al.	2005-05-05
Identification of compounds that inhibit replication of human immunodeficiency virus App 20040180893 - Balzarini, Jan Maria Rene ; et al.	2004-09-16
Molecules that block viral infectivity and methods of use thereof App 20040038908 - VAHLNE, ANDERS ; et al.	2004-02-26
Tripeptide amides that block viral infectivity and methods of use thereof App 20030060599 - Spoel, David van der ; et al.	2003-03-27
Protein polymerization inhibitors and methods of use App 20030050242 - Vahlne, Anders	2003-03-13
Pentamer Peptide Amide, Algpgnh2, Which Inhibits Viral Infectivity And Methods Of Use Thereof App 20030049611 - van der Spoel, David ; et al.	2003-03-13
Peptides that block viral infectivity and methods of use thereof App 20020091086 - Vahlne, Anders	2002-07-11
Peptides for use in vaccination and induction of neutralizing antibodies against human immunodeficiency virus Grant 5,840,313 - Vahlne , et al. November 24, 1	1998-11-24
Peptides for HTLV-2 infection diagnosis of, therapy for, vaccination against, for distinguishing between HTLV-1 and HTLV-2 infections and antibodies derived therefrom Grant 5,283,320 - Vahlne , et al. February 1, 1	1994-02-01
Peptides for the detection of HTLV-1 infection Grant 5,017,687 - Vahlne , et al. May 21, 1	1991-05-21
Synthetic peptide antigen for the detection of HIV-2 infection Grant 4,812,556 - Vahlne , et al. March 14, 1	1989-03-14

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.